Trump Sounds Alarm Over Prescription Drug Prices
Trump administration defends Medicare drug price talks in case brought by Novartis
The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate prescription drug prices, a sign that some consumer advocates said suggests the Trump administration is willing to maintain the controversial program.
The bill would tie prescription drug prices to federally negotiated rates under a program passed in the 1990s.
Money Talks News on MSN12h
Fixed Income, Rising Costs: Medicare Patients Face Skyrocketing Drug PricesMedicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...
Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...
House Democrats beat back a series of Republican amendments on party-line votes Wednesday, setting up a final vote on a ...
The latest weight-loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have list prices ranging from $900 to $1,500 for a one-month supply. David Ricks, the CEO of Mounjaro and Zepbound ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback